Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antidepressant prescribing in the precision medicine era: a prescriber’s primer on pharmacogenetic tools

8 Feb 2017

Abstract excerpt

About half of people who take antidepressants do not respond and many experience adverse effects. These detrimental outcomes are in part a result of the impact of an individual's genetic profile on pharmacokinetics and pharmcodynamics. If known and made available to clinicians, this could improve decision-making and antidepressant therapy outcomes. This has spurred the development of numerous...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Treatment and Pharmacology
Share to Pharmacogenetics and Drug Metabolism
Share to Treatment of Major Depression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28178974
DOI: 10.1186/s12888-017-1230-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antidepressant prescribing in the precision medicine era: a prescriber’s primer on pharmacogenetic toolsPMID 28178974Read ↗

A Call for Clear and Consistent Communications Regarding the Role of Pharmacogenetics in Antidepressant PharmacotherapySemantic proximity Read ↗

Pharmacogenetics of antidepressant drugs: current clinical practice and future directions.Semantic proximity Read ↗

Genotype, phenotype, and medication recommendation agreement among commercial pharmacogenetic-based decision support tools.Semantic proximity Read ↗

Clinical application of antidepressant pharmacogenetics: Considerations for the design of future studiesSemantic proximity Read ↗

Pharmacogenetics of antidepressant drugs: State of the art and clinical implementation - recommendations from the French National Network of Pharmacogenetics.Semantic proximity Read ↗

Clinical pharmacogenetics: how do we ensure a favorable future for patients?Semantic proximity Read ↗

Pharmacogenetics of mood disorders: what clinicians need to know.Semantic proximity Read ↗

Incorporating pharmacogenetics into clinical practice: reality of a new tool in psychiatry. Practical issues related to medication selection.Semantic proximity Read ↗

Atomoxetine Pharmacogenetics: Lessons Learned.Semantic proximity Read ↗

Pharmacogenetics and pharmacogenomics: using genetic information to guide therapeutic decision making.Semantic proximity Read ↗

Depression and Pharmacogenetics.Semantic proximity Read ↗

Antidepressant pharmacogeneticsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.